LA JOLLA PHARMACEUTICAL COMPANY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 13242
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 887
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 693
 
  
 
C07K PEPTIDES 3133
 
  
 
C07B GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 116
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169
 
  
 
C08B POLYSACCHARIDES; DERIVATIVES THEREOF 130
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0246,256 METHODS OF ADMINISTERING HEPCIDINJan 06, 17Aug 31, 17[A61K]
2017/0218,005 COMPOSITIONS AND METHODS RELATED TO GENTAMICINJan 27, 17Aug 03, 17[C07H, A61K]
2017/0196,931 Methods of Administering VasopressorsJan 06, 17Jul 13, 17[A61K]
2017/0014,446 COMPOSITIONS AND METHODS FOR ADMINISTERING GALECTIN ANTAGONISTSMar 10, 15Jan 19, 17[A61K]
2017/0014,471 COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURESep 30, 16Jan 19, 17[A61K]
2016/0346,317 Composition and Uses of Galectin AntagonistsFeb 26, 16Dec 01, 16[A61K]
2016/0074,465 Methods for Treating HypotensionJul 08, 15Mar 17, 16[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9457059 Compositions and methods for treating renal failureApr 28, 14Oct 04, 16[A61K]
9315545 Hepcidin mimetic peptides and uses thereofApr 07, 15Apr 19, 16[C07K]
9181354 Modified pectins, compositions and methods related theretoOct 30, 14Nov 10, 15[A61K, A01N, C08B, C08L]
8877263 Modified pectins, compositions and methods related theretoApr 16, 14Nov 04, 14[A01N, C08B]
8722107 Modified pectins, compositions and methods related theretoFeb 17, 12May 13, 14[A01N]
8722111 Modified pectins, compositions and methods related theretoMay 06, 13May 13, 14[A01N]
8658224 Modified pectins, compositions and methods related theretoMay 06, 13Feb 25, 14[A01N]
8420133 Modified pectins, compositions and methods related theretoAug 17, 12Apr 16, 13[A01N]
8409635 Modified pectins, compositions and methods related theretoAug 17, 12Apr 02, 13[A01N]
8128966 Modified pectins, compositions and methods related theretoMar 28, 05Mar 06, 12[A01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0051,013 HEPCIDIN MIMETIC PEPTIDES AND USES THEREOFAbandonedApr 14, 16Feb 23, 17[C07K]
2015/0133,399 COMPOSITION AND USES OF GALECTIN ANTAGONISTAbandonedDec 18, 14May 14, 15[A61K]
2010/0152,281 METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS HAVING SIGNIFICANTLY IMPAIRED RENAL FUNCTIONAbandonedOct 31, 08Jun 17, 10[A61K, A61P]
2009/0203,764 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASESAbandonedApr 20, 09Aug 13, 09[A61K, A61P]
2008/0293,660 CHEMICALLY-DEFINED NON-POLYMERIC VALENCY PLATFORM MOLECULES AND CONJUGATES THEREOFAbandonedApr 09, 08Nov 27, 08[A61K, C07H, A61P, C07K]
7351855 Chemically defined non-polymeric valency platform molecules and conjugates thereofExpiredJul 30, 03Apr 01, 08[A61K]
2007/0293,548 Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseasesAbandonedMar 30, 07Dec 20, 07[A61K, C07C, A61P]
2007/0254,851 Chemically-defined non-polymeric valency platform molecules and conjugates thereofAbandonedOct 02, 06Nov 01, 07[A61K, C07H, A61P, C07K]
2007/0218,072 METHODS OF IMPROVING HEALTH-RELATED QUALITY OF LIFE IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUSAbandonedNov 21, 06Sep 20, 07[A61K]
2007/0191,263 Valency platform molecules comprising aminooxy groupsAbandonedMar 26, 07Aug 16, 07[A61K]
2007/0191,297 METHODS OF TREATING AND MONITORING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALSAbandonedNov 30, 06Aug 16, 07[A61K, C07H]
2007/0179,111 METHODS OF TREATING PROTEINURIA BY REDUCING DOUBLE-STRANDED DNA ANTIBODIESAbandonedDec 20, 06Aug 02, 07[A61K]
7208156 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform moleculeExpiredFeb 20, 02Apr 24, 07[A61K]
2007/0078,157 Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (SSAO)enzyme activity and VAP-1 mediated adhesion useful for treatment of diseasesAbandonedNov 20, 06Apr 05, 07[A61K]
7163683 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform moleculeExpiredJul 16, 04Jan 16, 07[A61K]
7138244 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform moleculeExpiredOct 01, 04Nov 21, 06[G01N]
2006/0229,270 Methods of treating proteinuria by reducing double-stranded DNA antibodiesAbandonedMar 10, 06Oct 12, 06[A61K, C12N]
7115581 Chemically-defined non-polymeric valency platform molecules and conjugates thereofExpiredMay 10, 02Oct 03, 06[A61K]
2006/0217,333 Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal functionAbandonedFeb 02, 06Sep 28, 06[A61K, C07H]
7081242 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereofExpiredNov 28, 00Jul 25, 06[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.